Exposure to Spoken Communication During the COVID-19 Pandemic Among Children With Cochlear Implants.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
02 10 2023
Historique:
medline: 30 10 2023
pubmed: 27 10 2023
entrez: 27 10 2023
Statut: epublish

Résumé

School closures and other COVID-19-related restrictions could decrease children's exposure to speech during important stages of development. To assess whether significant decreases in exposure to spoken communication found during the initial phase of the COVID-19 pandemic among children using cochlear implants are confirmed for a larger cohort of children and were sustained over the first years of the COVID-19 pandemic. This cohort study used datalogs collected from children with cochlear implants during clinical visits to a tertiary pediatric hospital in Toronto, Ontario, Canada, from January 1, 2018, to November 11, 2021. Children with severe to profound hearing loss using cochlear implants were studied because their devices monitored and cataloged levels and types of sounds during hourly use per day (datalogs) and because their hearing and spoken language development was particularly vulnerable to reduced sound exposure. Statistical analyses were conducted between January 2022 and August 2023. Daily hours of sound were captured by the cochlear implant datalogging system and categorized into 6 auditory scene categories, including speech and speech-in-noise. Time exposed to speech was calculated as the sum of daily hours in speech and daily hours in speech-in-noise. Residual hearing in the ear without an implant of children with unilateral cochlear implants was measured by pure tone audiometry. Mixed-model regression analyses revealed main effects with post hoc adjustment of 95% CIs using the Satterthwaite method. Datalogs (n = 2746) from 262 children (137 with simultaneous bilateral cochlear implants [74 boys (54.0%); mean (SD) age, 5.8 (3.5 years)], 38 with sequential bilateral cochlear implants [24 boys (63.2%); mean (SD) age, 9.1 (4.2) years], and 87 with unilateral cochlear implants [40 boys (46.0%); mean (SD) age, 7.9 (4.6) years]) who were preschool aged (n = 103) and school aged (n = 159) before the COVID-19 pandemic were included in analyses. There was a slight increase in use among preschool-aged bilateral cochlear implant users through the pandemic (early pandemic, 1.4 h/d [95% CI, 0.3-2.5 h/d]; late pandemic, 2.3 h/d [95% CI, 0.6-4.0 h/d]) and little change in use among school-aged bilateral cochlear implant users (early pandemic, -0.6 h/d [95% CI, -1.1 to -0.05 h/d]; late pandemic, -0.3 h/d [95% CI, -0.9 to 0.4 h/d]). However, use decreased during the late pandemic period among school-aged children with unilateral cochlear implants (-1.8 h/d [95% CI,-3.0 to -0.6 h/d]), particularly among children with good residual hearing in the ear without an implant. Prior to the pandemic, children were exposed to speech for approximately 50% of the time they used their cochlear implants (preschool-aged children: bilateral cochlear implants, 46.6% [95% CI, 46.5%-47.2%] and unilateral cochlear implants, 52.1% [95% CI, 50.7%-53.5%]; school-aged children: bilateral cochlear implants, 47.6% [95% CI, 46.8%-48.4%] and unilateral cochlear implants, 51.0% [95% CI, 49.4%-52.6%]). School-aged children in both groups experienced significantly decreased speech exposure in the early pandemic period (bilateral cochlear implants, -12.1% [-14.6% to -9.4%]; unilateral cochlear implants, -15.5% [-20.4% to -10.7%]) and late pandemic periods (bilateral cochlear implants, -5.3% [-8.0% to -2.6%]; unilateral cochlear implants, -11.2% [-15.3% to -7.1%]) compared with the prepandemic baseline. This cohort study using datalogs from children using cochlear implants suggests that a sustained reduction in children's access to spoken communication was found during more than 2 years of COVID-19 pandemic-related lockdowns and school closures.

Identifiants

pubmed: 37889489
pii: 2811118
doi: 10.1001/jamanetworkopen.2023.39042
pmc: PMC10611997
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2339042

Références

Brain Sci. 2021 Aug 09;11(8):
pubmed: 34439670
Cochlear Implants Int. 2021 Mar;22(2):85-95
pubmed: 33008284
JAMA Pediatr. 2020 Jul 1;174(7):665-675
pubmed: 32202633
Int J Lang Commun Disord. 2015 May-Jun;50(3):358-73
pubmed: 25556640
Otol Neurotol. 2021 Sep 1;42(8):1156-1164
pubmed: 34049333
J Am Acad Child Adolesc Psychiatry. 1993 May;32(3):585-94
pubmed: 8496123
Am J Emerg Med. 2021 Jul;45:100-104
pubmed: 33677263
Laryngoscope. 2013 Sep;123(9):2270-5
pubmed: 23483556
Int J Pediatr Otorhinolaryngol. 2012 Mar;76(3):339-44
pubmed: 22209332
Otolaryngol Head Neck Surg. 2002 May;126(5):505-11
pubmed: 12075224
Cochlear Implants Int. 2009 Jun;10(2):84-91
pubmed: 18949762
Depress Anxiety. 2021 May 5;:
pubmed: 33949747
Otol Neurotol. 2016 Feb;37(2):e110-7
pubmed: 26756142
Otolaryngol Head Neck Surg. 2022 Apr;166(4):603-604
pubmed: 34933634
J Am Acad Audiol. 2016 Nov/Dec;27(10):824-838
pubmed: 27885978
Int J Audiol. 2018 May;57(sup2):S105-S111
pubmed: 29020839
MMWR Morb Mortal Wkly Rep. 2020 Apr 10;69(14):422-426
pubmed: 32271728
J Speech Lang Hear Res. 2021 May 11;64(5):1636-1649
pubmed: 33887149
J Am Acad Audiol. 2014 Apr;25(4):380-7
pubmed: 25126685
Ear Hear. 2020 May/Jun;41(3):678-685
pubmed: 31567563
Pediatrics. 2020 Jun;145(6):
pubmed: 32179660
Pediatrics. 2017 Aug;140(2):
pubmed: 28689189
J Am Acad Child Adolesc Psychiatry. 1987 Jul;26(4):546-53
pubmed: 3654509
JAMA Otolaryngol Head Neck Surg. 2021 Apr 1;147(4):368-376
pubmed: 33599710
Eur J Sport Sci. 2022 Jul;22(7):1094-1103
pubmed: 33641633
J Am Acad Audiol. 2018 Oct;29(9):835-846
pubmed: 30278868
Sci Rep. 2020 Dec 11;10(1):21780
pubmed: 33311526
Int J Audiol. 2014 Aug;53(8):564-76
pubmed: 25005776
Ear Hear. 2021 Jul-Aug 01;42(4):1042-1053
pubmed: 33974791
Pediatrics. 2021 Mar;147(3):
pubmed: 33328339
Child Dev. 2021 Mar;92(2):609-625
pubmed: 33547640
Int J Lang Commun Disord. 2009 Jan-Feb;44(1):36-55
pubmed: 18608602
N Engl J Med. 2007 Dec 6;357(23):2380-7
pubmed: 18057340
Lang Speech Hear Serv Sch. 2013 Jan;44(1):73-88
pubmed: 22869089
Semin Hear. 2021 Dec 09;42(4):321-330
pubmed: 34912160
S Afr J Commun Disord. 2022 Feb 09;69(1):e1-e7
pubmed: 35144436
Am Ann Deaf. 2018;163(1):35-60
pubmed: 29731472
Otolaryngol Head Neck Surg. 2022 Jan;166(1):171-178
pubmed: 34032520
JAMA Netw Open. 2021 Oct 1;4(10):e2128611
pubmed: 34618041
Ear Hear. 2017 Nov/Dec;38(6):681-689
pubmed: 28542017
J Pediatr. 2021 Dec;239:59-66.e1
pubmed: 34461061
Otol Neurotol. 2020 Jan;41(1):39-44
pubmed: 31498292
Front Psychol. 2021 Mar 18;12:569920
pubmed: 33815187

Auteurs

Emily Wener (E)

Archie's Cochlear Implant Laboratory, The Hospital for Sick Children, Toronto, Ontario, Canada.

Lindsay Booth (L)

Archie's Cochlear Implant Laboratory, The Hospital for Sick Children, Toronto, Ontario, Canada.

Hailey Bensky (H)

Archie's Cochlear Implant Laboratory, The Hospital for Sick Children, Toronto, Ontario, Canada.

Veeral Desai (V)

Archie's Cochlear Implant Laboratory, The Hospital for Sick Children, Toronto, Ontario, Canada.

Jaina Negandhi (J)

Archie's Cochlear Implant Laboratory, The Hospital for Sick Children, Toronto, Ontario, Canada.

Sharon L Cushing (SL)

Archie's Cochlear Implant Laboratory, The Hospital for Sick Children, Toronto, Ontario, Canada.
Department of Otolaryngology-Head & Neck Surgery, University of Toronto, Toronto, Ontario, Canada.
Department of Otolaryngology, The Hospital for Sick Children, Toronto, Ontario, Canada.

Blake C Papsin (BC)

Archie's Cochlear Implant Laboratory, The Hospital for Sick Children, Toronto, Ontario, Canada.
Department of Otolaryngology-Head & Neck Surgery, University of Toronto, Toronto, Ontario, Canada.
Department of Otolaryngology, The Hospital for Sick Children, Toronto, Ontario, Canada.

Karen A Gordon (KA)

Archie's Cochlear Implant Laboratory, The Hospital for Sick Children, Toronto, Ontario, Canada.
Department of Otolaryngology-Head & Neck Surgery, University of Toronto, Toronto, Ontario, Canada.
Department of Communication Disorders, The Hospital for Sick Children, Toronto, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH